Frontal vs Parietal Eminence Drainage for Chronic Subdural Hematoma
Frontal Versus Parietal Eminence Twist-Drill Drainage for Chronic Subdural Hematoma
2 other identifiers
interventional
440
1 country
3
Brief Summary
This clinical trial aims to find out whether the puncture site used during minimally invasive surgery with twist-drill puncture and closed-system drainage affects the treatment of chronic subdural hematoma (cSDH). The target population is adults with a unilateral chronic subdural hematoma who need surgical drainage based on their symptoms and imaging findings (CT/MRI). The main questions this study is designed to answer are:
- Does the puncture site affect the risk of same-side cSDH recurrence requiring reoperation within 3 months
- Does the puncture site affect recovery and key clinical outcomes after surgery (including functional status and postoperative recovery measures) There are two groups, researchers will compare:
- Group A: patients receiving puncture at the frontal region vs.
- Group B: patients receiving puncture near the parietal eminence to determine whether one puncture site leads to better outcomes than the other. Participants will:
- undergo a surgical procedure where, based on random assignment, the puncture site is either frontal or near the parietal eminence;
- receive closed-system drainage after a twist-drill puncture;
- complete follow-up assessments at discharge, 30 days, 3 months after surgery, which will include symptom review and imaging (CT) evaluations to check hematoma changes and recurrence;
- have safety monitoring throughout the study period to record any complications or adverse events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2027
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2026
CompletedFirst Posted
Study publicly available on registry
July 28, 2026
CompletedStudy Start
First participant enrolled
January 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
Study Completion
Last participant's last visit for all outcomes
June 1, 2029
July 28, 2026
July 1, 2026
1.9 years
July 22, 2026
July 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ipsilateral cSDH recurrence requiring reoperation within 3 months after surgery
Recurrence defined as ipsilateral hematoma re-enlargement or symptom recurrence, confirmed by imaging, and judged by the treatment team to require repeat surgical intervention.
3 months
Secondary Outcomes (9)
Residual hematoma maximum thickness
"Day 2", "Month 1", "Month3" after operation
Residual hematoma volume
"Day 2", "Month 1", "Month3" after operation
Intra-cranial pneumocephalus volume
"Day 2", "Month 1" after operation
Improvement in midline shift
"Day 2", "Month 1", "Month3" after operation
Drain duration / catheter indwelling time
immediately after the procedure
- +4 more secondary outcomes
Study Arms (2)
Frontal (Anterior) Burr Hole Puncture Drainage (twist-drill drainage)
EXPERIMENTALThe puncture point is selected within the anterior coverage region of the hematoma area-typically within the frontal bone region anterior to the coronal suture-avoiding the frontal sinus, obvious cortical veins, and key functional areas. The exact location is determined based on preoperative CT 3D reconstruction, with principles of safe entry into the subdural hematoma space and an appropriate catheter direction toward the main hematoma cavity/compartment.
Parietal Eminence Burr Hole Puncture Group(twist-drill drainage)
ACTIVE COMPARATORThe puncture point is selected at the vertex (crown vertex) region within the hematoma area. The exact location is determined based on preoperative CT 3D reconstruction, with principles of safe entry into the subdural hematoma space and an appropriate catheter direction toward the main hematoma cavity/compartment.
Interventions
Patients will undergo burr-hole puncture drainage at the frontal region (frontal puncture) for chronic subdural hematoma (cSDH).
Patients will undergo burr-hole puncture drainage at the Parietal Eminence/tubercle region (vertex puncture) for cSDH.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years.
- Unilateral chronic subdural hematoma (cSDH) or subacute-to-chronic subdural hematoma, confirmed by CT or MRI.
- Presence of clinical symptoms attributable to cSDH, such as headache, limb weakness, gait disturbance, cognitive decline, speech disturbance, seizure, or impaired consciousness.
- Radiological indication for surgery, defined as one of the following:
- Maximum hematoma thickness ≥ 10 mm, and/or Midline shift ≥ 5 mm, or Even if these thresholds are not met, clinically significant symptoms requiring surgery as judged by the treating neurosurgeon.
- Plan to undergo twist-drill puncture drainage with a closed drainage system.
- Written informed consent signed by the participant or their legally authorized representative.
You may not qualify if:
- Bilateral cSDH requiring simultaneous bilateral surgery.
- Acute subdural hematoma, or a condition where the hematoma is predominantly composed of an acute hemorrhagic component.
- Markedly septated, organized, or calcified hematoma in which minicraniotomy or craniotomy is required preoperatively.
- Previous surgery on the ipsilateral side for cSDH.
- Concomitant intracranial conditions requiring specific treatment, including but not limited to: intracranial tumor, brain abscess, vascular malformation, or ruptured aneurysm.
- Severe coagulation disorder that cannot be corrected before surgery.
- Life expectancy \< 6 months.
- Pregnancy.
- Any condition that, in the judgment of the investigator, makes the patient inappropriate for participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Second Hospital of Anhui Medical Universitylead
- Yangzhou Universitycollaborator
- Huai'an First People's Hospitalcollaborator
Study Sites (3)
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230601, China
Huai'an First People's Hospital
Huai'an, Jiangsu, 223300, China
Yangzhou University Affiliated Hospital
Yangzhou, Jiangsu, 225009, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
qi li, MD
The Second Hospital of Anhui Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Surgeons and operating room staff cannot be masked because of the nature of the surgical intervention. Radiological outcome assessors, clinical outcome assessors when feasible, members of the endpoint adjudication committee, and statistical analysts will be masked to treatment allocation until the primary analysis is completed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 22, 2026
First Posted
July 28, 2026
Study Start (Estimated)
January 1, 2027
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
June 1, 2029
Last Updated
July 28, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share